**Question:** How would a drug that competes with Ach for receptors at the motor end plate effect skeletal muscle? It would

A. increase the duration of action of acetylcholine
B. prolong the response of the muscle
C. reduce the response of the muscle
D. prevent the muscle from relaxing

**Core Concept:**

Acetylcholine (Ach) is a neurotransmitter responsible for transmitting signals from the motor neuron to the skeletal muscle. At the motor end plate of the neuromuscular junction, Ach binds to nicotinic acetylcholine receptors (nAChRs), which are ligand-gated ion channels that allow the influx of ions, resulting in muscle contraction.

**Why the Correct Answer is Right:**

A drug that competes with Ach for these receptors would effectively reduce the number of available receptors for Ach to bind to. This would result in less activation of the receptors and fewer ions entering the muscle cell, leading to a reduced muscle response. In this context, the correct answer represents the reduction in muscle response due to the competition for receptors at the motor end plate.

**Why Each Wrong Option is Incorrect:**

A. Increasing the duration of Ach action would result in a prolonged muscle contraction, not a reduced response.
B. Prolonging the muscle response would not reduce the overall response of the muscle, but rather increase it.
C. Reducing the response of the muscle is the correct answer, not the opposite.
D. Preventing the muscle from relaxing would essentially mean preventing the muscle from contracting, not reducing its response.

**Clinical Pearl:**

Understanding the pharmacology of neuromuscular transmission is essential in clinical practice, particularly in cases involving neuromuscular disorders or medications affecting this process, such as anticholinesterase drugs used for treatment of Alzheimer's disease. This concept helps us comprehend how drugs can interfere with neuromuscular transmission and the subsequent effects on muscle function.